AKT1 and acute myeloid leukemia: In AML, aberrant activation of PI3K/AKT and NF-κB pathways mediates chemoresistance in this disease, and the activation of these pathways is closely related to the differentiation of T cells and cell cycle regulation (Evangelisti et al., 2020; Kodous, Balaiah & Ramanathan, 2023).